Finding Description
Based on observation interview, and record review, the facility failed to monitor for the continued need for a PRN (as needed) antianxiety medication for 1 of 5 residents reviewed for unnecessary medications. (Resident 1)Findings included:A record review was completed on 12/19/2025 at 11:16 A.M. for Resident 1. Diagnoses included, but were not limited to, anxiety disorder.An admission Minimum Data Set (MDS) assessment, dated 11/26/2025, indicated Resident 1's cognition was intact she had not exhibited any behavior issues and she had received antianxiety medication.Current Physician Orders included, but were not limited to:-On 11/20/2025 lorazepam 1 milligram (mg) by mouth 3 times a day as needed (PRN) for anxiety, discontinue on 11/21/2025.-On 11/21/2025 lorazepam 1 mg by mouth 3 times a day as needed for anxiety, discontinue on 11/25/2025.-On 11/25/2025 lorazepam 1 mg by mouth 3 times a day as needed for anxiety, discontinue on 12/5/2025.-On 12/10/2025 lorazepam 1 mg by mouth 3 times a day as needed for anxiety, discontinue on 12/11/2025.-On 12/11/2025 lorazepam 1 mg by mouth 3 times a day as needed for anxiety, discontinue on 12/23/2025. A Care Plan problem, dated 11/26/2025, indicated Resident 1 was at risk for signs and symptoms of anxiety. Interventions included, maintain a calm environment or move to a quiet area, administer medications as ordered, and psychological services as needed.There was no documentation of Resident 1's symptoms of anxiety prior to administering an as needed (PRN) lorazepam. In addition, there was no documentation of any non-pharmacological interventions attempted and effectiveness of the interventions prior to the administration of the medication. Finally, there was no documentation of the effectiveness of the lorazepam medication.During an interview on 12/23/2025 at 9:48 A.M., Resident 1 indicated sometimes she could not sleep because her mind was racing and it (the lorazepam medication) helped to calm her so she could sleep. In addition, Resident 1 indicated the other reasons she asked for the medication was if it was not time for her pain medication, it helped to calm her and brought her anxiety down from 7 or 8 to 5 rate while she waited on her next dose of pain medication.During an interview on 12/23/2025 at 9:53 A.M., LPN 2 indicated Resident 1 was overall visibly very anxious and her pulse and respirations were elevated. She also indicated she does not usually document in the Nurses Progress Notes because when signing out the lorazepam in the medication administration record, she marked it was for anxiety. She indicated she had tried non-pharmaceutical interventions but she had not documented them.During an interview on 12/23/2025 at 9:58 A.M., the DON indicated that best practice would have been to document symptoms and reasons for the PRN lorazepam, non-pharmacological interventions tried, and the effectiveness of the lorazepam.On 12/23/2025 at 10:03 A.M. the DON indicated there was not a policy that specifically addressed PRN psychotropic medications.3.1-48(a)(3)